2020
DOI: 10.1007/s11356-020-10114-6
|View full text |Cite
|
Sign up to set email alerts
|

The fate of biocontrol agents under the European phytopharmaceutical regulation: how this regulation hinders the approval of botanicals as new active substances

Abstract: The use of biocontrol agents (BCAs) is growing across the world and in Europe in particular, where novel ways of farming are highly encouraged and implemented. However, although the social pressure is high to increase the number of BCAs in use within the EU, the European plant protection products (PPP) regulation (EC) N°1107/2009 does not define clearly what BCAs are. Therefore, problems and drawbacks are observed throughout the whole authorisation process. Consequently, this situation impedes drastically the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 21 publications
0
13
0
Order By: Relevance
“…International cooperation is increasing and the USA and Canada review biopesticides jointly to increase registration efficiency and grower access to more sustainable pest management solutions (Leahy et al ., 2014). Even in cases where the regulatory requirements are clear, the pest and environmental risk assessments for gaining approval to commercialize a microbial biocontrol agent/biopesticide may be cost‐prohibitive (Köhl et al ., 2019) and this has hampered innovation in some jurisdictions, most notably in the EU (Frederiks & Wesseler, 2019; Vekemans & Marchand, 2020). In jurisdictions that are ‘claims based’ (i.e.…”
Section: Product Commercializationmentioning
confidence: 99%
“…International cooperation is increasing and the USA and Canada review biopesticides jointly to increase registration efficiency and grower access to more sustainable pest management solutions (Leahy et al ., 2014). Even in cases where the regulatory requirements are clear, the pest and environmental risk assessments for gaining approval to commercialize a microbial biocontrol agent/biopesticide may be cost‐prohibitive (Köhl et al ., 2019) and this has hampered innovation in some jurisdictions, most notably in the EU (Frederiks & Wesseler, 2019; Vekemans & Marchand, 2020). In jurisdictions that are ‘claims based’ (i.e.…”
Section: Product Commercializationmentioning
confidence: 99%
“…The EU Pesticides Database [ 52 ] was used to detect basic substances and their status (approved, nonapproved, pending, and modifications of Review Reports). Corresponding linked Implementing Regulations [ 20 ] attached to each active substance were found using the same method and cross-verified with Implementing Regulation (EU) 540/2011.…”
Section: Methodsmentioning
confidence: 99%
“…Regardless of the above suggestions to improve research in this subject and ensure better formulations of bio-insecticides, allowing for sufficient persistence of their stability, quality and insecticidal effect, there is still a major obstacle that only delays the adoption of bio-insecticides in the detriment of conventional synthetic insecticides. Probably the biggest impairment is the regulatory environments that changes according to countries legislations [ 111 ]. Health and environmental problems caused by insecticides in the past are the common denominators that lead to strict criteria for the registration of new insecticides, e.g., in Europe [ 112 ] and in the USA [ 113 ].…”
Section: Final Considerations and Future Perspectivesmentioning
confidence: 99%